Phyzone Injection contains Phytomenadione 1mg, an injectable vitamin K indicated for the prevention and treatment of vitamin K deficiency, hemorrhagic disorders, and coagulation-related conditions. It helps in maintaining proper blood clotting and preventing bleeding complications.
Phytomenadione works by facilitating the synthesis of clotting factors II, VII, IX, and X in the liver, ensuring effective coagulation. Its injectable formulation allows rapid administration in acute deficiency or emergency settings.
For distributors and healthcare suppliers, Phyzone Injection is a high-demand hematology therapy product, commonly used in hospitals, neonatal care units, and clinics managing coagulation disorders. The ongoing need for vitamin K supplementation supports steady year-round demand.
Adding Phyzone Injection to your coagulation and hematology therapy segment creates strong opportunities in hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, prescriber trust, and critical therapeutic use make it a valuable addition to pharmaceutical distribution portfolios.